| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 09/27/2001 | US20010024749 Surface modified carbonaceous materials |
| 09/27/2001 | DE19960898A1 Preparation of a wide range of annelated pyrroles useful as photographic cyan dye couplers by reaction of heterocyclic carbonyl compounds with substituted phosphoric oxides or phosphonium salts in presence of a strong base |
| 09/27/2001 | CA2403828A1 Inhibitors of p38 |
| 09/27/2001 | CA2402655A1 Process for the preparation of midazolam |
| 09/27/2001 | CA2402516A1 Non-amidine containing protease inhibitors |
| 09/26/2001 | EP1135683A2 New assay |
| 09/26/2001 | EP1135392A2 Process for preparing cross-bridged tetraaza macrocycles |
| 09/26/2001 | EP1135391A1 Novel triazolo(4,5-d)pyrimidine compounds |
| 09/26/2001 | EP0528991B1 Detectably labelled marker component comprising a fluorophore moiety , fluorescent probe comprising the marker component and uses thereof. |
| 09/26/2001 | CN1314999A Modulating multiple lineage kinase proteins |
| 09/26/2001 | CN1314356A Mampalon hemotoidin and mampalon haem and their preparing method |
| 09/26/2001 | CN1071753C 7-azabicyclo [2,2,1]-heptane and heptene derivatives as cholinergic receptor ligands |
| 09/25/2001 | US6294532 Oxindolylquinazoline derivatives as angiogenesis inhibitors |
| 09/25/2001 | US6294530 Heterocyclic compounds for nervous system disorders |
| 09/25/2001 | US6294525 Reverse-turn mimetics and methods relating thereto |
| 09/25/2001 | US6294517 Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
| 09/20/2001 | WO2001068649A1 Novel process for the preparation of a quinoline carboxylic acid derivative having a 7-(4-aminomethyl-3-oxime)pyrrolidine substituent |
| 09/20/2001 | WO2001068637A2 Method for the preparation of tetrahydrobenzothiepines |
| 09/20/2001 | WO2001068619A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | WO2001068099A1 Modulation of cardiovascular injury |
| 09/20/2001 | WO2001068096A2 Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders |
| 09/20/2001 | WO2001027118A3 Bicyclic imidazo-5-yl-amine derivatives |
| 09/20/2001 | WO2001027110A3 Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring |
| 09/20/2001 | WO2001027109A3 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 09/20/2001 | WO2000047583A9 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 09/20/2001 | US20010023286 Core, cladding structure |
| 09/20/2001 | US20010023248 Antiinflammatory agents, central nervous system disorders |
| 09/20/2001 | CA2403017A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | CA2402645A1 Modulation of cardiovascular injury |
| 09/20/2001 | CA2402549A1 Substituted beta-carbolines |
| 09/19/2001 | EP1133531A1 Water soluble fluorescent dyes free of aggregation and serum binding and related products and methods |
| 09/19/2001 | EP0880522B1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE DERIVATIVES AMPA AND NMDA RECEPTORS ANTAGONISTS, PREPARATION THEREOF, INTERMEDIATES THEREOF AND DRUGS CONTAINING SAME |
| 09/19/2001 | EP0874849B1 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives |
| 09/19/2001 | EP0538297B1 Antiviral tetrahydroimidazo 1,4]benzodiazepin-2-(thio)ones |
| 09/19/2001 | CN1313769A Pharmaceutical combination comprising A COX-2 inhibitor and a iNOS inhibitor |
| 09/19/2001 | CN1313286A S type 4-substituted hydroxypyranoindolidine compound and its derivatives and preparation thereof |
| 09/19/2001 | CN1071361C Fibre-reactive dyestuffs |
| 09/19/2001 | CN1071118C Pyrazolopyrimidone for treating impotence |
| 09/18/2001 | US6291678 Process for the preparation of chiral keto-heterocycles of basic amino acids |
| 09/18/2001 | US6291508 Potent ability to bind to retinoic acid receptors thus useful in treating psoriasis and rheumatoid arthritis. |
| 09/18/2001 | US6291501 Specifically exemplified herein are dragmacidin f, topsentin d, and topsentin e, and their salts, analogs, and derivatives. |
| 09/18/2001 | US6291473 Treating anxiety, depression, post-traumatic stress disorder, inflammatory diseases, obesity, in mammals |
| 09/18/2001 | US6291460 Treatment of anxiety; treatment and/or prevention of convulsions |
| 09/18/2001 | US6291448 Carbapenem antibacterial compounds, compositions containing such compounds and method of treatment |
| 09/18/2001 | US6291447 Inhibiting the g2 checkpoint in a cell |
| 09/13/2001 | WO2001066550A2 Compounds for pdt |
| 09/13/2001 | WO2001066549A1 Intermediate compounds |
| 09/13/2001 | WO2001066548A1 New aza-indolyl derivatives |
| 09/13/2001 | WO2001066534A2 Cyclic and bicyclic diamino histamine-3 receptor antagonists |
| 09/13/2001 | WO2001066521A1 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 09/13/2001 | WO2001066099A2 Use of quinazoline derivatives as angiogenesis inhibitors |
| 09/13/2001 | WO2000052012A3 A method for synthesizing porphyrin compounds |
| 09/13/2001 | US20010021775 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor Xa |
| 09/13/2001 | US20010020310 Oxidation dyeing |
| 09/13/2001 | CA2402433A1 Compounds for pdt |
| 09/13/2001 | CA2399111A1 New aza-indolyl derivatives |
| 09/12/2001 | EP1132390A2 Diazepinoindoles as phophodiesterase inhibitors |
| 09/12/2001 | EP1132389A1 New aza-indolyl derivatives for the treatment of obesity |
| 09/12/2001 | EP1131324A2 Method for the demethoxycarbonylation of porphyrinic compounds such as pheophorbides |
| 09/12/2001 | EP1131322A2 Dihydropyridine compounds and methods of use |
| 09/12/2001 | EP1131295A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 09/12/2001 | EP1131288A1 Pyrrolidine derivatives-ccr-3 receptor antagonists |
| 09/12/2001 | EP0835241B1 Water based coating composition containing an aminoplast-ether copolymer |
| 09/12/2001 | EP0711773B1 Hymenialdisine and derivative thereof, process for producing intermediate for synthesizing the same, and said intermediate |
| 09/12/2001 | CN1312816A Metallocenyl phthalocyanines dye |
| 09/12/2001 | CN1312812A Muscarinic agonists and antagonists |
| 09/12/2001 | CN1312805A Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 09/12/2001 | CN1312729A Dry powder dispersing apparatus and method therefor |
| 09/12/2001 | CN1312339A Material having pigment coating on its substrate, and its use and digital-information reading method |
| 09/12/2001 | CN1312251A Preparation of partially synthesized deuteroporphyrin derivative and its freeze dried injection |
| 09/12/2001 | CN1312246A Process for preparing carboxylic acid |
| 09/12/2001 | CN1070861C Bicyclic amidine and its use as catalyst |
| 09/12/2001 | CN1070856C Thiazole derivative |
| 09/11/2001 | US6288234 Fluorinated heterocyclic amido amine compounds as drugs |
| 09/11/2001 | US6288185 Initiators for radical polymerization |
| 09/11/2001 | US6288099 Compounds such as 8-bromo-10h-benzo(4,5)furo(3,2-b)indole-1-carboxylic acid used to treat disorders associated with smooth muscle contration such as urinary incontinence and irritable bowl syndrome |
| 09/11/2001 | US6288070 Triazolopurine derivatives, medicinal composition containing the derivatives, adenosine A3 receptor compatibilizing agent, and asthmatic remedy |
| 09/11/2001 | US6288056 Intermittent claudication therapeutic drugs comprising pyrroloazepines |
| 09/11/2001 | US6288055 Analgesic agents |
| 09/11/2001 | CA2227991C 1,2,4-triazolo¬1,5-c|pyrimidine heterocyclic analogues having antagonistic activity on adenosine a2a receptor |
| 09/11/2001 | CA2217728C Pyrazolo ¬1,5-a| pyrimidine derivatives |
| 09/07/2001 | WO2001064679A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 09/07/2001 | WO2001064678A2 Inhibitors of hepatitis c virus ns3 protease |
| 09/07/2001 | WO2001064677A1 Novel imidazotriazinones and the use thereof |
| 09/07/2001 | WO2001064674A1 2,4-disubstituted thiazolyl derivatives |
| 09/07/2001 | WO2001064226A2 Farnesyl protein transferase inhibitor combinations with platinum compounds |
| 09/07/2001 | WO2001064197A2 Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives |
| 09/07/2001 | WO2001016135A3 Reverse-turn mimetics and methods relating thereto |
| 09/07/2001 | WO2001014379A3 A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor |
| 09/07/2001 | CA2401834A1 Novel imidazotriazinones and the use thereof |
| 09/07/2001 | CA2397657A1 Farnesyl protein transferase inhibitor combinations with platinum compounds |
| 09/07/2001 | CA2397253A1 Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives |
| 09/07/2001 | CA2396504A1 Inhibitors of hepatitis c virus ns3 protease |
| 09/06/2001 | US20010020034 Isothiazole derivatives useful as anticancer agents |
| 09/06/2001 | DE10010067A1 New 2-phenyl-imidazo (5,1-f) (1,2,4) triazin-4-one derivatives, are phosphodiesterase inhibitors useful for treating cardiovascular, cerebrovascular or urogenital disorders |
| 09/05/2001 | EP1129706A2 Use of cGMP PDE5 inhibitors for the treatment of neuropathy |
| 09/05/2001 | EP1129690A2 Keratin fibre dye compositions containing indolizine cationic derivatives and dyeing method |
| 09/05/2001 | EP1129097A1 Novel type condensed pyridazinone compounds |
| 09/05/2001 | EP1129096A2 Crf receptor antagonists and methods relating thereto |
| 09/05/2001 | EP1129095A1 Process for preparing cross-bridged tetraaza macrocycles |